Part of the 2017 Midwest Gala Dinner was dedicated to honoring the contributions of Jeff Aronin. The gala is a function which is hosted yearly by the Weizmann Institute of Science for the region of the Midwest. This specific year was dedicated to Aronin for his two decades of successful involvement in the development of biotech and healthcare innovation industries around the globe.
Jeff Aronin is a businessman, innovator, and mentor with comprehensive expertise in drug development and the study of rare diseases and complex sciences. He has served as the chairperson and chief executive officer of Paragon Biosciences since 2010. Paragon a chain of companies which perform research in the biopharmaceutical sector.
Before joining Paragon Biosciences, Jeff Aronin was the president and CEO of Ovation Pharmaceuticals between 2000 and 2009. Other than Paragon and Ovation, Aronin has also served as the chief executive officer to several companies in different parts of the globe that deal with the biopharmaceutical industry (https://www.weizmann-usa.org/get-involved/attend-an-event/2017-midwest-gala-dinner-honoring-jeffrey-aronin).
Jeff Aronin is known for his excellent leadership skills, skills in brand marketing, finance handling, business development and his strategic way of carrying out his activities (WorldBusinessChicago). His vast experience also plays a helping role in all the companies he works for and all the projects in which he partakes. Jeff also has a passion for sharing his knowledge with fellow entrepreneurs to whom he acts as a mentor. He is fond of bringing together great and talented groups of scientists and leaders to work jointly to research new therapies and drug treatments.
It may come as a surprise to many that this successful man also carries in his sleeves vast experience in the field of mergers and acquisition. This just goes to show that there is nothing that Aronin cannot tackle if he sets his mind to it. This makes him worthy recipient of the honors given to him at the 2017 Midwest Gala Dinner.